- •Preface
- •List of contributers
- •History, epidemiology, prevention and education
- •A history of burn care
- •“Black sheep in surgical wards”
- •Toxaemia, plasmarrhea, or infection?
- •The Guinea Pig Club
- •Burns and sulfa drugs at Pearl Harbor
- •Burn center concept
- •Shock and resuscitation
- •Wound care and infection
- •Burn surgery
- •Inhalation injury and pulmonary care
- •Nutrition and the “Universal Trauma Model”
- •Rehabilitation
- •Conclusions
- •References
- •Epidemiology and prevention of burns throughout the world
- •Introduction
- •Epidemiology
- •The inequitable distribution of burns
- •Cost by age
- •Cost by mechanism
- •Limitations of data
- •Risk factors
- •Socioeconomic factors
- •Race and ethnicity
- •Age-related factors: children
- •Age-related factors: the elderly
- •Regional factors
- •Gender-related factors
- •Intent
- •Comorbidity
- •Agents
- •Non-electric domestic appliances
- •War, mass casualties, and terrorism
- •Interventions
- •Smoke detectors
- •Residential sprinklers
- •Hot water temperature regulation
- •Lamps and stoves
- •Fireworks legislation
- •Fire-safe cigarettes
- •Children’s sleepwear
- •Acid assaults
- •Burn care systems
- •Role of the World Health Organization
- •Conclusions and recommendations
- •Surveillance
- •Smoke alarms
- •Gender inequality
- •Community surveys
- •Acknowledgements
- •References
- •Prevention of burn injuries
- •Introduction
- •Burns prevalence and relevance
- •Burn injury risk factors
- •WHERE?
- •Burn prevention types
- •Burn prevention: The basics to design a plan
- •Flame burns
- •Prevention of scald burns
- •Conclusions
- •References
- •Burns associated with wars and disasters
- •Introduction
- •Wartime burns
- •Epidemiology of burns sustained during combat operations
- •Fluid resuscitation and initial burn care in theater
- •Evacuation of thermally-injured combat casualties
- •Care of host-nation burn patients
- •Disaster-related burns
- •Epidemiology
- •Treatment of disaster-related burns
- •The American Burn Association (ABA) disaster management plan
- •Summary
- •References
- •Education in burns
- •Introduction
- •Surgical education
- •Background
- •Simulation
- •Education in the internet era
- •Rotations as courses
- •Mentorship
- •Peer mentorship
- •Hierarchical mentorship
- •What is a mentor
- •Implementation
- •Interprofessional education
- •What is interprofessional education
- •Approaches to interprofessional education
- •References
- •European practice guidelines for burn care: Minimum level of burn care provision in Europe
- •Foreword
- •Background
- •Introduction
- •Burn injury and burn care in general
- •Conclusion
- •References
- •Pre-hospital and initial management of burns
- •Introduction
- •Modern care
- •Early management
- •At the accident
- •At a local hospital – stabilization prior to transport to the Burn Center
- •Transportation
- •References
- •Medical documentation of burn injuries
- •Introduction
- •Medical documentation of burn injuries
- •Contents of an up-to-date burns registry
- •Shortcomings in existing documentation systems designs
- •Burn depth
- •Burn depth as a dynamic process
- •Non-clinical methods to classify burn depth
- •Burn extent
- •Basic principles of determining the burn extent
- •Methods to determine burn extent
- •Computer aided three-dimensional documentation systems
- •Methods used by BurnCase 3D
- •Creating a comparable international database
- •Results
- •Conclusion
- •Financing and accomplishment
- •References
- •Pathophysiology of burn injury
- •Introduction
- •Local changes
- •Burn depth
- •Burn size
- •Systemic changes
- •Hypovolemia and rapid edema formation
- •Altered cellular membranes and cellular edema
- •Mediators of burn injury
- •Hemodynamic consequences of acute burns
- •Hypermetabolic response to burn injury
- •Glucose metabolism
- •Myocardial dysfunction
- •Effects on the renal system
- •Effects on the gastrointestinal system
- •Effects on the immune system
- •Summary and conclusion
- •References
- •Anesthesia for patients with acute burn injuries
- •Introduction
- •Preoperative evaluation
- •Monitors
- •Pharmacology
- •Postoperative care
- •References
- •Diagnosis and management of inhalation injury
- •Introduction
- •Effects of inhaled gases
- •Carbon monoxide
- •Cyanide toxicity
- •Upper airway injury
- •Lower airway injury
- •Diagnosis
- •Resuscitation after inhalation injury
- •Other treatment issues
- •Prognosis
- •Conclusions
- •References
- •Respiratory management
- •Airway management
- •(a) Endotracheal intubation
- •(b) Elective tracheostomy
- •Chest escharotomy
- •Conventional mechanical ventilation
- •Introduction
- •Pathophysiological principles
- •Low tidal volume and limited plateau pressure approaches
- •Permissive hypercapnia
- •The open-lung approach
- •PEEP
- •Lung recruitment maneuvers
- •Unconventional mechanical ventilation strategies
- •High-frequency percussive ventilation (HFPV)
- •High-frequency oscillatory ventilation
- •Airway pressure release ventilation (APRV)
- •Ventilator associated pneumonia (VAP)
- •(a) Prevention
- •(b) Treatment
- •References
- •Organ responses and organ support
- •Introduction
- •Burn shock and resuscitation
- •Post-burn hypermetabolism
- •Individual organ systems
- •Central nervous system
- •Peripheral nervous system
- •Pulmonary
- •Cardiovascular
- •Renal
- •Gastrointestinal tract
- •Conclusion
- •References
- •Critical care of thermally injured patient
- •Introduction
- •Oxidative stress control strategies
- •Fluid and cardiovascular management beyond 24 hours
- •Other organ function/dysfunction and support
- •The nervous system
- •Respiratory system and inhalation injury
- •Renal failure and renal replacement therapy
- •Gastro-intestinal system
- •Glucose control
- •Endocrine changes
- •Stress response (Fig. 2)
- •Low T3 syndrome
- •Gonadal depression
- •Thermal regulation
- •Metabolic modulation
- •Propranolol
- •Oxandrolone
- •Recombinant human growth hormone
- •Insulin
- •Electrolyte disorders
- •Sodium
- •Chloride
- •Calcium, phosphate and magnesium
- •Calcium
- •Bone demineralization and osteoporosis
- •Micronutrients and antioxidants
- •Thrombosis prophylaxis
- •Conclusion
- •References
- •Treatment of infection in burns
- •Introduction
- •Clinical management strategies
- •Pathophysiology of the burn wound
- •Burn wound infection
- •Cellulitis
- •Impetigo
- •Catheter related infections
- •Urinary tract infection
- •Tracheobronchitis
- •Pneumonia
- •Sepsis in the burn patient
- •The microbiology of burn wound infection
- •Sources of organisms
- •Gram-positive organisms
- •Gram-negative organisms
- •Infection control
- •Pharmacological considerations in the treatment of burn infections
- •Topical antimicrobial treatment
- •Systemic antimicrobial treatment (Table 3)
- •Gram-positive bacterial infections
- •Enterococcal bacterial infections
- •Gram-negative bacterial infections
- •Treatment of yeast and fungal infections
- •The Polyenes (Amphotericin B)
- •Azole antifungals
- •Echinocandin antifungals
- •Nucleoside analog antifungal (Flucytosine)
- •Conclusion
- •References
- •Acute treatment of severely burned pediatric patients
- •Introduction
- •Initial management of the burned child
- •Fluid resuscitation
- •Sepsis
- •Inhalation injury
- •Burn wound excision
- •Burn wound coverage
- •Metabolic response and nutritional support
- •Modulation of the hormonal and endocrine response
- •Recombinant human growth hormone
- •Insulin-like growth factor
- •Oxandrolone
- •Propranolol
- •Glucose control
- •Insulin
- •Metformin
- •Novel therapeutic options
- •Long-term responses
- •Conclusion
- •References
- •Adult burn management
- •Introduction
- •Epidemiology and aetiology
- •Pathophysiology
- •Assessment of the burn wound
- •Depth of burn
- •Size of the burn
- •Initial management of the burn wound
- •First aid
- •Burn blisters
- •Escharotomy
- •General care of the adult burn patient
- •Biological/Semi biological dressings
- •Topical antimicrobials
- •Biological dressings
- •Other dressings
- •Exposure
- •Deep partial thickness wound
- •Total wound excision
- •Serial wound excision and conservative management
- •Full thickness burns
- •Excision and autografting
- •Topical antimicrobials
- •Large full thickness burns
- •Serial excision
- •Mixed depth burn
- •Donor sites
- •Techniques of wound excision
- •Blood loss
- •Antibiotics
- •Anatomical considerations
- •Skin replacement
- •Autograft
- •Allograft
- •Other skin replacements
- •Cultured skin substitutes
- •Skin graft take
- •Rehabilitation and outcome
- •Future care
- •References
- •Burns in older adults
- •Introduction
- •Burn injury epidemiology
- •Pathophysiologic changes and implications for burn therapy
- •Aging
- •Comorbidities
- •Acute management challenges
- •Fluid resuscitation
- •Burn excision
- •Pain and sedation
- •End of life decisions
- •Summary of key points and recommendations
- •References
- •Acute management of facial burns
- •Introduction
- •Anatomy and pathophysiology
- •Management
- •General approach
- •Airway management
- •Facial burn wound management
- •Initial wound care
- •Topical agents
- •Biological dressings
- •Surgical burn wound excision of the face
- •Wound closure
- •Special areas and adjacent of the face
- •Eyelids
- •Nose and ears
- •Lips
- •Scalp
- •The neck
- •Catastrophic injury
- •Post healing rehabilitation and scar management
- •Outcome and reconstruction
- •Summary
- •References
- •Hand burns
- •Introduction
- •Initial evaluation and history
- •Initial wound management
- •Escharotomy and fasciotomy
- •Surgical management: Early excision and grafting
- •Skin substitutes
- •Amputation
- •Hand therapy
- •Secondary reconstruction
- •References
- •Treatment of burns – established and novel technology
- •Introduction
- •Partial thickness burns
- •Biological membranes – amnion and others
- •Xenograft
- •Full thickness burns
- •Dermal analogs
- •Keratinocyte coverage
- •Facial transplantation
- •Tissue engineering and stem cells
- •Gene therapy and growth factors
- •Conclusion
- •References
- •Wound healing
- •History of wound care
- •Types of wounds
- •Mechanisms of wound healing
- •Hemostasis
- •Proliferation
- •Epithelialization
- •Remodeling
- •Fetal wound healing
- •Stem cells
- •Abnormal wound healing
- •Impaired wound healing
- •Hypertrophic scars and keloids
- •Chronic non-healing wounds
- •Conclusions
- •References
- •Pain management after burn trauma
- •Introduction
- •Pathophysiology of pain after burn injuries
- •Nociceptive pain
- •Neuropathic pain
- •Sympathetically Maintained Pain (SMP)
- •Pain rating and documentation
- •Pain management and analgesics
- •Pharmacokinetics in severe burns
- •Form of administration [21]
- •Non-opioids (Table 1)
- •Paracetamol
- •Metamizole
- •Non-steroidal antirheumatics (NSAID)
- •Selective cyclooxygenasis-2-inhibitors
- •Opioids (Table 2)
- •Weak opioids
- •Strong opioids
- •Other analgesics
- •Ketamine (see also intensive care unit and analgosedation)
- •Anticonvulsants (Gabapentin and Pregabalin)
- •Antidepressants with analgesic effects
- •Regional anesthesia
- •Pain management without analgesics
- •Adequate communication
- •Psychological techniques [65]
- •Transcutaneous electrical nerve stimulation (TENS)
- •Particularities of burn pain
- •Wound pain
- •Breakthrough pain
- •Intervention-induced pain
- •Necrosectomy and skin grafting
- •Dressing change of large burn wounds and removal of clamps in skin grafts
- •Dressing change in smaller burn wounds, baths and physical therapy
- •Postoperative pain
- •Mental aspects
- •Intensive care unit
- •Opioid-induced hyperalgesia and opioid tolerance
- •Hypermetabolism
- •Psychic stress factors
- •Risk of infection
- •Monitoring [92]
- •Sedation monitoring
- •Analgesia monitoring (see Fig. 2)
- •Analgosedation (Table 3)
- •Sedation
- •Analgesia
- •References
- •Nutrition support for the burn patient
- •Background
- •Case presentation
- •Patient selection: Timing and route of nutritional support
- •Determining nutritional demands
- •What is an appropriate initial nutrition plan for this patient?
- •Formulations for nutritional support
- •Monitoring nutrition support
- •Optimal monitoring of nutritional status
- •Problems and complications of nutritional support
- •Conclusion
- •References
- •HBO and burns
- •Historical development
- •Contraindications for the use of HBO
- •Conclusion
- •References
- •Nursing management of the burn-injured person
- •Introduction
- •Incidence
- •Prevention
- •Pathophysiology
- •Severity factors
- •Local damage
- •Fluid and electrolyte shifts
- •Cardiovascular, gastrointestinal and renal system manifestations
- •Types of burn injuries
- •Thermal
- •Chemical
- •Electrical
- •Smoke and inhalation injury
- •Clinical manifestations
- •Subjective symptoms
- •Possible complications
- •Clinical management
- •Non-surgical care
- •Surgical care
- •Coordination of care: Burn nursing’s unique role
- •Nursing interventions: Emergent phase
- •Nursing interventions: Acute phase
- •Nursing interventions: Rehabilitative phase
- •Ongoing care
- •Infection prevention and control
- •Rehabilitation medicine
- •Nutrition
- •Pharmacology
- •Conclusion
- •References
- •Outpatient burn care
- •Introduction
- •Epidemiology
- •Accident causes
- •Care structures
- •Indications for inpatient treatment
- •Patient age
- •Total burned body surface area (TBSA)
- •Depth of the burn
- •Pre-existing conditions
- •Accompanying injuries
- •Special injuries
- •Treatment
- •Initial treatment
- •Pain therapy
- •Local treatment
- •Course of treatment
- •Complications
- •Infections
- •Follow-up care
- •References
- •Non-thermal burns
- •Electrical injury
- •Introduction
- •Pathophysiology
- •Initial assessment and acute care
- •Wound care
- •Diagnosis
- •Low voltage injuries
- •Lightning injuries
- •Complications
- •References
- •Symptoms, diagnosis and treatment of chemical burns
- •Chemical burns
- •Decontamination
- •Affection of different organ systems
- •Respiratory tract
- •Gastrointestinal tract
- •Hematological signs
- •Nephrologic symptoms
- •Skin
- •Nitric acid
- •Sulfuric acid
- •Caustic soda
- •Phenol
- •Summary
- •References
- •Necrotizing and exfoliative diseases of the skin
- •Introduction
- •Necrotizing diseases of the skin
- •Cellulitis
- •Staphylococcal scalded skin syndrome
- •Autoimmune blistering diseases
- •Epidermolysis bullosa acquisita
- •Necrotizing fasciitis
- •Purpura fulminans
- •Exfoliative diseases of the skin
- •Stevens-Johnson syndrome
- •Toxic epidermal necrolysis
- •Conclusion
- •References
- •Frostbite
- •Mechanism
- •Risk factors
- •Causes
- •Diagnosis
- •Treatment
- •Rewarming
- •Surgery
- •Sympathectomy
- •Vasodilators
- •Escharotomy and fasciotomy
- •Prognosis
- •Research
- •References
- •Subject index
Review of geriatric burn care
following inhalation injury [69]. Burn injury may also uncover comorbidities not diagnosed prior to the event. At autopsy, approximately 75% of patients aged ≥65 have evidence of ischemic heart disease [15]. Demling noted a 61% incidence of pre-existing protein energy malnutrition in hospitalized burn patients > 65 years old, associated with twice the hospital mortality rate compared to well-nourished patients [70]. Given their disparity, the impact of pre-existing conditions on burn outcomes is only beginning to be elucidated [71, 72]. Severe burn injuries are unlike elective surgery situations where preoperative optimization is possible, yet much work can be done to address co-morbidities in the intensive care unit, on the acute care ward, and at the time of hospital discharge. Preoperative optimization, however, is advisable with smaller size burns, for which the risks of the surgical procedure may outweigh the benefits of early wound closure. The contribution of geriatric specialists to the burn multidisciplinary care team model is another potential area for investigation, as it has already shown to benefit older patients with trauma and hip fractures [73, 74].
Acute management challenges
Fluid resuscitation
Recent publications on fluid administration highlight the phenomenon of excess fluid administration compared to prediction formulas, and describe the associated complications of elevated compartment pressures and acute lung injury [75–77]. Despite that, the incidence of acute kidney injury following resuscitation remains unacceptably high, and disproportionately affects aged patients [58, 78]. These data reinforce the adage that aged patients are less able to tolerate either overor under-resuscitation because of limited cardiopulmonary reserve. However, what constitutes a proper resuscitation remains unclear as there is lack of agreement among providers on the type and composition of fluids for aged burn patients [44, 79]. A recent multicenter observational study found that age was inversely related to volume of fluid administered, meaning that providers likely limited fluid infusion in aged patients [76]. A commonly cited rationale is the concern for excess
edema formation in the lung. Accumulation of extravascular lung water (EVLW) as a result of high volume resuscitation is often posited, yet has not been proven to occur following burns [80, 81]. There are two potential explanations for this finding: first, that central hydrostatic pressures do not become elevated despite high volume administration during burn resuscitation, and second, that EVLW accumulation is more closely associated with direct lung injury from inhalation, or secondary lung injury from shock and sepsis, rather than changes in Starling forces during resuscitation [82, 83]. In the absence of convincing data to guide proper resuscitation in aged adults, it is prudent to initiate resuscitation for all adults according to weight and burn size according to standard formulas, and subsequently adjust according to individual patient response.
Burn excision
Early excision has reduced mortality and decreased length of stay in pediatric and adult patients [84, 85]. Early excision in older adults, however remains controversial as multiple centers have indicated a lack of improvement in mortality, infection rates, and length of stay [11, 86–89]. Delayed wound healing and poor graft take are important limitations to wound closure in older patients. Despite harvesting thin grafts, it is often not possible to safely re-harvest from the same donor sites within several weeks. Interstices in expanded mesh grafts are slow to fill, and both grafted beds and donor sites are more prone to infection. In 1987, Herd et al. argued for a prospective randomized trial of early excision in older patients, given the lack of benefit at the authors’ institution [88]. In contrast, others have reported that older adults generally tolerate surgical excision well, and several centers have noted improved survival with an early excision approach [3, 6, 90–92]. The definition of early excision has also varied in the literature, with a range of 72 hours to 7 days post-injury. In 2010, this issue remains one of the major unanswered questions in modern burn care, where the results of a wellconducted prospective evaluation could potentially alter care paradigms throughout the world. Our current practice at the University of Washington Burn Center is to perform surgical excision following completion of fluid resuscitation, and before 7 days in
283
T. N. Pham
older patients with burns ≥ 20% TBSA. Our rationale for early excision is that older patients do not tolerate burn wound sepsis and that removal of the burn wound is essential for survival [33, 92].
Pain and sedation
Appropriate pain management in aging adults has been historically hampered by two contradictory, yet widely held beliefs: first, that pain perception decreases with age, and second, that chronic pain in geriatric patients is so prevalent that it is assumed to be part of “normal aging”. Pain research in older adults has proliferated over the past 20 years. It has helped characterize the complex and diverse causes of geriatric pain. Although older patients report decreased acute pain perception in certain circumstances, such as that associated with acute myocardial infarction, they are at increased risk of neuropathic pain with tissue injury, temporal summation and persistent hyperalgesia [93, 94]. Older patients are more likely to become disabled by pain than younger adults [95]. Pathways to adaptation to chronic pain perception may also differ middle age and older patient groups [96]. Thus pain does not simply increase or decrease with age. Rather different types of pain are affected differently by aging. The current framework conceptualizes geriatric pain as a disease associated with an underlying condition, rather than an unavoidable part of aging [97].
Pain assessment and treatment are both challenging in this population. Multiple studies have established that the standard visual analog scale (VAS) has limited value in older patients [98, 99]. Instead, pain experts currently recommend using numeric rating scales (NRS), verbal description scales (VDS), or the McGill Pain Questionnaire [97]. Observational scales become necessary when cognitive impairment or mechanical ventilation preclude self-re- porting. Numerous observational measurements have been specifically developed for older patients over the past 20 years [100]. Whether these tools can be validated for older burn patients or a new scale should be developed remains a topic for investigation. Burn providers are also appropriately cautious when using pharmacologic agents to relieve pain in older adults [101]. Common side-effects of non-ster- oidal inflammatory agents are GI bleeding and renal
toxicity. The initial opioid analgesic dose for acute pain should be 25–50% of that in younger adults and carefully titrated upwards to achieve comfort [102]. Titration is paramount as undertreated pain is a risk factor for acute delirium and postoperative cognitive dysfunction (POCD) [103]. Barbiturates, benzodiazepines, and tricyclic antidepressants are other classes of agents that require caution in older patients because of decreased clearance and side effects. Pharmacists and geriatricians’ expertise can contribute greatly to the multidisciplinary team in carefully titrating medications and minimizing of polypharmacy.
Acute delirium in the intensive care unit is an active area of research, with nearly 2,000 published manuscripts in the past 4 years. Criteria to diagnose acute delirium are 1) the acute onset of mental status change or fluctuating course, 2) inattention, and 3) disorganized thinking or altered level of consciousness [104]. Although providers easily recognize hyperactive delirium in agitated patients who pose a danger to themselves and their environment, hypoactive delirium is much more common and under-recognized. In this instance, the patient appears apathetic, withdrawn, and has decreased responsiveness. Acute delirium disproportionately affects older hospitalized patients because of pain, infection, inadequate sedation and intrinsic host factors such as mild dementia. Deeper sedation and higher severity of illness are other recognized risk factors for delirium. Data from surgical and mixedICU indicate that acute delirium is a risk factor for death and poor longterm outcomes [105, 106]. The benzodiazepine lorazepam has been implicated as an independent risk factor for delirium, whereas the newer sedation agent dexmedetomidine appears to decrease the incidence of delirium [107]. Until now, few pain and sedation studies have enrolled burn patients aged ≥ 65. However, we anticipate that future research will clarify the roles of traditional pharmacologic relief of pain, newer agents for sedation, and non-pharmacologic approaches to improve the care of older burn patients.
End of life decisions
Not infrequently in the burn intensive care unit, providers withhold or withdraw life-sustaining ther-
284